J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
Adrian G. McNicholl,Dmitry S. Bordin,Alfredo J. Lucendo,Galina Dmitrivna Fadeenko,Manuel Castro Fernández,Irina Voynovan,Natalia Valerievna Zakharova,Aiman Silkanovna Sarsenbaeva,Luis Bujanda,Ángeles Pérez-Aisa,Liudmila Vologzhanina,Oleg Zaytsev,Tatiana Ilchishina,Cristobal De la Coba,Jorge Pérez Lasala,S A Alekseenko,Ines Modolell,Javier Molina-Infante,Rafael Ruíz-Zorrilla López,Horacio Alonso-Galan,Nuria Fernandez Moreno,Jen Hinojosa,Inmaculada Santaella,Pilar Varela,Pedro L. Gonzalez-Cordero,Jesús Barrio,José Luis Domínguez-Jiménez,O. Nunez,Javier Alcedo,Olga P Nyssen,Maria Caldas,Maria G. Donday,Oleg Shvetz,Francis Mégraud,Colm O'Morain,Javier P. Gisbert +35 more
TL;DR: The addition of bismuth to 14-day standard triple therapy with clarithromycin and amoxicillin is found to eradicate H pylori infection in more than 90% of patients, based on intention to treat analysis, with an acceptable safety profile and level of adherence.
Journal ArticleDOI
Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
TL;DR: A systematic search of the online bibliographic database PubMed from inception to August 2020 with screening in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted as mentioned in this paper.
Journal ArticleDOI
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week—a meta‐analysis of efficacy
TL;DR: To compare the efficacy of proton pump inhibitor vs. ranitidine bismuth citrate (RBC) with two antibiotics for 1 week in Helicobacter pylori eradication, a comparison study is conducted using a single tablet of RBC.
Journal ArticleDOI
Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin.
TL;DR: This data indicates that once the H. pylori infection is eliminated in patients allergic to penicillin, the risk of serious adverse events, particularly in children, is reduced.
Journal ArticleDOI
Treatment of Helicobacter pylori infection 2013.
TL;DR: This review summarizes important studies regarding Helicobacter pylori therapy published from April 2012 up to March 2013, finding that cure rates for standard triple therapy remain acceptable in quite a few settings nowadays, and some reports on innovative triple therapies look promising.